A clinical research containing dietary habits of 454 IBD patients provided one possible mechanism that the Mediterranean diet was negatively associated with FGF-19, and that the farnesol X receptor-FGF-19 axis is considered a potential therapeutic target for IBD. The gene discussed is FGF19; the disease is inflammatory bowel disease.